Background: The Frontal Assessment Battery (FAB) is a short battery designed to assess frontal executive functioning, but data for interpretation of performance are limited. Objectives: The Trinity, Ulster, Department of Agriculture (TUDA) study provided the opportunity to derive performance data from a large sample of community-dwelling hospital outpatient or general practitioner (GP) attenders. Methods: Normative analysis based on 2508 TUDA participants meeting these criteria: Mini-Mental State Examination (MMSE) >26/30, not depressed (Center for Epidemiologic Studies Depression <16) or anxious (Hospital Anxiety and Depression Scale <8), no history of stroke, or transient ischemic attack. Correlation and regression analyses were used to evaluate the effects of age, education, gender, and general cognition (MMSE). Norms for FAB were created stratified by age and education, using overlapping midpoint ranges of 10 years with a 3-year interval from age 60 to 97. Results: Age and education accounted for 9.6% of variance in FAB score (r 2 ¼ .096) with no significant effect of gender. The FAB and MMSE were modestly correlated (r ¼ .29, P < .01) with MMSE increasing the model's total explained variance in FAB score from 9.6% to 14%.
Introduction
The Frontal Assessment Battery (FAB) was designed to provide a brief bedside cognitive and behavioral battery to assess frontal executive functioning.
1 It consists of 6 brief subtests evaluating similarities (conceptualization), verbal fluency (mental flexibility), motor programming, resistance to interference, inhibitory control, and environmental autonomy. It is becoming increasingly widely used, and Kopp et al 2 have identified 2 broad applications: (1) early and differential diagnosis of neurodegenerative diseases, in particular, behavioral variant frontotemporal dementia and Alzheimer disease (AD) [3] [4] [5] [6] and (2) detection of executive dysfunction in various diseases that affect frontostriatal brain networks including Parkinson disease, [7] [8] [9] [10] Huntington disease, 11 amyotrophic lateral sclerosis, 12, 13 multiple system atrophy and progressive supranuclear palsy, [14] [15] [16] psychiatric disorders (eg, depression in Parkinson disease, 17, 18 addictive substance abuse [19] [20] , and stroke.
2, 21 The FAB has been well validated as sensitive to frontal lobe dysfunction and concords well with more detailed neuropsychological testing.
1,14 Significant correlations have also been shown between the FAB subtests and frontal metabolism in positron emission tomography (fluorodeoxyglucose positron emission tomography, FDG-PET) studies of patients with varying frontal lobe damage 22 and AD. 23 However, in keeping with other tests designed to target frontal lobe functioning, the FAB is not entirely specific to frontostriatal dysfunction. In a singlephoton emission computed tomography study in Parkinson disease, Matsui et al 24 reported that parietal lobe dysfunction in addition to frontal lobe dysfunction contributed to reduced performance on FAB. Of note, Lee et al 23 found significant correlations in patients with AD between FAB scores and FDG-PET metabolism in various cortical regions including temporal and parietal cortices and frontal regions independent of age, gender, and education. However, after controlling for the effect of global disease severity (Mini-Mental State Examination [MMSE] ), significant correlations between FAB and metabolism were found only in the bilateral prefrontal regions. To control for possible dyspraxic or aphasic confounds on FAB performance, Kopp et al 2 did a magnetic resonance imaging voxel-based lesion-behavior mapping study of FAB sensitivity to frontal lobe damage in patients with right hemisphere damaged first-ever stroke and concluded that several FAB scores including composite and item scores provided valid measures of right hemisphere lateral frontal dysfunction, particularly in the region of the anterior insula, middle frontal gyrus, and inferior frontal gyrus.
It is somewhat surprising given its widespread use that it is not entirely clear what constitutes impaired range performance on the FAB, with no clear recommendation for a cutoff score. Some limited control group (n ¼ 42) versus patient group information was provided in the original paper 1 with control FAB ¼ 17.3 + 0.8 (mean + standard deviation [SD]), which suggests that FAB < 16/18 would be ''abnormal.'' However, <16/18 is not at all uncommon based on 4 studies that provide some limited normative information, 2 Italian (n ¼ 236 and n ¼ 364, respectively), 25, 26 1 Brazilian (n ¼ 391), 27 and 1 Korean (n ¼ 635). 28 Iavarone et al 25 found that 95% of their normal controls had a FAB score 12/18. For discriminating AD from normal controls, Kim et al 28 recommended a cutoff score of 10/11 (sensitivity 72% and specificity 83%). Slachevsky et al 3 found a cutoff score of 12 as optimal to differentiate frontotemporal dementia from AD in mildly demented patients (sensitivity 77% and specificity 87%).
An issue for interpreting performance on any test is the nature of the control sample. When stringent inclusion/ exclusion criteria are applied, as is often the case, the control sample may comprise a ''hypernormal'' or ''supernormal'' sample that it not representative of the range of healthy individual performance encountered in the real world. 29 The alternative is to avoid over selective criteria (eg, Appollonio et al 26 and Duff et al 30 ) , which was an approach adopted in the present study.
Aim of the Present Article
The Trinity, Ulster, Department of Agriculture (TUDA) study 31 provided the opportunity to derive normative data from a large sample of community-dwelling hospital or general practitioner (GP) attenders that may be of benefit for reference purposes to interpret FAB performance in older adults.
Methods Sample
The TUDA study has been described elsewhere. 31 It is a large cross-sectional study designed to create a phenotype/genotype database for 3 cohorts of community-dwelling adults older than 60 years attending outpatient hospital clinics (bone, cognitive cohorts) or GP (hypertensive cohort). For the TUDA study, individuals who were able to provide consent and scored 16 on MMSE were eligible for recruitment commencing in December 2008 and completed in September 2012. For the present study, data on the FAB were available for 2508 TUDA participants who met the following criteria: MMSE >26/30, not depressed on the Center for Epidemiologic Studies Depression 32 (CESD <16) scale, not anxious on the anxiety subscale of the Hospital Anxiety and Depression Scale 33 (HADS anxiety <8), no history of stroke, or transient ischemic attack (TIA). These criteria were applied with the intention of selecting a sample with ''normal'' range cognition on MMSE 34 without significant depression, anxiety, history of stroke, or TIA. Functional status was evaluated on the Instrumental Activities of Daily Living (IADL) scale. 35 All participants provided written consent, and ethical approval was obtained from research ethnic committees. Trained researchers and doctors conducted the study assessments.
Statistical Analysis
Statistical advice was sought and concluded that given the absence of any large outliers, the data are sufficiently robust for parametric analysis. Correlation and regression analyses were used to evaluate the effects of age, education, gender, and general cognition (MMSE) on the FAB. Based on the results of the regression modeling, a table of norms for FAB scores was created stratified by age and education (primary, secondary, and tertiary) using overlapping midpoint ranges of 10 years with a 3-year interval from age 60 to 97. This approach was adopted based on the previous work comparing several different methods for producing normative data for the MMSE and Montreal Cognitive Assessment, with the current method offering advantages of optimized data usage by maximizing the number of participants contributing to the normative distribution at each midpoint age interval. 30, 36, 37 This approach is similar to the overlapping strata approach recommended by Kim et al. 28 For each age/education stratum, data were presented in the form of mean, standard deviation, median, and range from 5th to 95th percentile.
Results
The sample characteristics are summarized in Table 1 . The sample aged in range from 60 to 95 years (mean age + SD, 71.73 + 7.36), with 67% of females. In terms of medical comorbidities, these included hypertension (71.45%), hyperlipidemia (52.39%), diabetes (11.64%), and ischemic heart disease (11.48%). As expected, given the inclusion/exclusion criteria, MMSE was high (28.44 + 1.0) as was the level of functional ability (IADL scale ¼ 25.8 + 3.08), whereas levels were low for anxiety (HADS anxiety ¼ 2.0 + 2.08) and depression (CESD ¼ 3.34 + 3.72). Of note, regarding alcohol consumption, 14.39% of the sample were past drinkers, 62.16% were current drinkers, and 23.45% never drank. Rates of chronic alcoholism were not recorded, but data on units of alcohol consumed per week were available for 87.15% of female current drinkers (n ¼ 868) and for 96.27% of male current drinkers (n ¼ 542). We evaluated how many current drinkers drank above the recommended levels (health recommendations from Irish Health Services Executive [HSE] 38 : 14 U per week for females and 21 U per week for males). A total of 10.71% of female current drinkers and 26.38% of male current drinkers drank above the recommended limits, and this represents 9.4% of the entire sample.
The distribution of FAB scores was skewed due to a ceiling effect. In a linear regression model age and education accounted for 9.6% of the variance in FAB scores (r 2 ¼ .096), while no significant effect of gender was identified (adding gender to the model did not alter the estimates). The FAB and MMSE were correlated (r ¼ .29, P < .01) with the addition of MMSE to the model increasing the explained variance in FAB scores from 9.6% to 14%.
Discussion
This is the largest study to date to create normative data for the FAB. Consistent with previous studies, [25] [26] [27] [28] age and education but not gender were found to have significant impacts on FAB performance, which was largely though not entirely independent of global cognition as assessed by the MMSE (including MMSE in the regression model increased explained variance in FAB scores from 9.6% to 14%). Performance at the 10th percentile (a commonly used normative cutoff for below average performance) 39 was found on the FAB to fall between approximately 10/18 and 14/18 depending on the above factors.
The sample comprises individuals who were attending hospital clinics or GP practices and are not free of disease as evidenced by the presence of hypertension (71.45%), hyperlipidemia (52.39%), diabetes (11.64%), or ischemic heart disease (11.48%). Regarding alcohol consumption, 14.39% of the sample were past drinkers, 62.16% current drinkers, and 23.45% never drank. Data available for 87.15% of female current drinkers and 96.27% of male current drinkers indicated that 10.71% of female current drinkers and 26.38% of male current drinkers drank above the recommended levels (HSE health recommendations). 38 This sampling approach can be seen either as a limitation or a strength of the study, depending on one's perspective. As a limitation, the question arises as to the limited general applicability of these normative data, given the presence of medical comorbidities and other factors that can impact executive functioning. On the other hand, the common practice of selecting as controls individuals who are free of a variety of factors present in the general aging population leads to a problem of supernormal controls who are not in fact representative of the general population and while considered as representing ''normality'' are likely to be performing at ''above average'' levels. The crucial issue in selecting norms for test interpretation is whether a given control sample is similar in character (eg, demographics, health status, etc) to the cases for whom the control data are being use for normative comparison. The current data provide a large reference sample for comparison of individuals who are hospital clinics or GP attenders with medical comorbidities. Individuals in our normative sample are not cognitively impaired on MMSE and are functionally normal without anxiety, depression, a history of stroke, or TIA.
The issues of supernormal controls versus limited general applicability when stringent inclusion/exclusion criteria are applied or not applied was also addressed by Duff et al when developing norms for the widely used Repeatable Battery for the Assessment of Neuropsychological Status. They selected a sample that included medical comorbidities (15% with cancer, 17% with diabetes, 46% with hypertension). They argued that their sample likely represents what the American Psychological Association (APA) Working Group on the Older Adult 40 refer to as ''typical'' aging (which includes older adults with 1 or more medical illnesses), which can be contrasted with ''optimal'' aging (individuals who report no physical illnesses and have aged particularly well). For normative comparison purposes, optimal aging individuals are more akin to hypernormal or supernormal controls who do not represent the range of healthy individual performance encountered in everyday settings. Strauss et al 39 argue that using exclusion criteria in older adults based on health status may disproportionately restrict normative samples because of the increased prevalence of medical and other conditions in this age group. The result is a 'normal' sample that includes only the upper ranges of scores for older individuals, and which will disproportionately render impairment scores for low functioning but typically ageing elders. (p. 52)
There are therefore arguments for and against the use of more or less stringent inclusion/exclusion criteria. In the end, the best practice is to find the ''best fit'' between a patient's demographic characteristics and those of the study sample, as recommended by Mitrushina et al. 41 In conclusion, the norms presented here provide a useful reference to interpret performance on the FAB in research or clinical settings. 
